21 Oct 2024

Reference: CIR-2024-00000191

 To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the MOHAP for perusal and adherence to what is stated

Circular No.9217for the year 2024 Alert Against the use of Counterfeit version of medicinal product

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Mounjaro 2.5mg-5mg-10mg-12.5mg-15mg-4 Single dose prefilled pens 00.pdf

download